PTX3 and COVID-19: Kerget et al. [185] conducted a cross-sectional study with a sample of COVID-19 patients to investigate the relationships between PTX3 gene polymorphisms (rs2305619 (281A/G) and rs1840680 (1449A/G)) and the development of macrophage activation syndrome (MAS) during the active disease.